Pear Therapeutics (Thimble Point Acquisition) ^{Priced, Nasdaq: PEAR}

We are a newly-organized blank check company incorporated on December 1, 2020, as a Delaware corporation. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue an acquisition opportunity in any industry or geographic region, we currently intend to focus on high-growth software and technology-enabled companies that are disrupting large and established industries and markets. The members of our management team are associated with the Pritzker Vlock Family Office, a multi-billion-dollar family office that invests in companies and their management teams with industry changing ideas, as well as LaunchCapital, a premier venture capital firm with offices in Boston, New Haven and New York. In these and other capacities, our management team’s decades of combined experience in the private and public markets has centered on selecting and supporting high-growth companies that use technology innovation as the core competitive advantage to win over the long-term in large established markets.